CRISPR Based Technologies and Bio-products

Genome editing and the utilization of CRISPR primarily based technologies are expected to revolutionize the assembly of the next generation of bio products. DCB12 can focus on the most recent developments within the use of CRISPR/Cas9 and alternative CRISPR primarily based technologies in reference to the development and production of biopharmaceuticals, biochemicals, agricultural crops and travel applications.

    Related Conference of CRISPR Based Technologies and Bio-products

    January 21-21, 2021

    Genetics and Molecular biology

    Paris, France
    September 27-28, 2021

    15th International Conference on Genomics & Pharmacogenomics

    Vancouver, Canada
    December 07-08, 2021

    2nd World Congress on Cell and Structural Biology

    Sydney, Australia
    December 09-10, 2021

    2nd International Conference on Geriatrics and Ageing

    Sydney, Australia

    CRISPR Based Technologies and Bio-products Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in